References
- Önder S, Ozturk M. How does omalizumab affect the immunoinflammatory response in patients with chronic spontaneous urticaria? Cutan Ocul Toxicol 2019;6:1–5.
- Zuberbier T, Aberer W, Asero R, et al. The EAACI/GA (2) LEN/EDF/WAO guideline for the definition, classification, diagnosis, and management of urticaria: the 2013 revision and update. Allergy 2014;69:868–887.
- Grzanka A, Machura E, Misiolek M, et al. Systemic inflammatory response and calcification markers in patients with long lasting moderate-severe chronic spontaneous urticaria. Eur J Dermatol 2015;25:26–28.
- Kasperska-Zajac A. Acute-phase response in chronic urticaria. J Eur Acad Dermatol 2012;26:665–672.
- Kaplan AP, Greaves M. Pathogenesis of chronic urticaria. Clin Exp Allergy 2009;39:777–787.